Ribavirin API Manufacturers
compare suppliers & get competitive offers
Filters
Reset
Selected filters:
Type
Production region
Qualifications
Country of origin
Follow us
Distributor
Produced in:
Established in: 2005
MOQ: -
Employees: 200+
Portfolio of over 2,000 APIs
Precise quality control
End-to-end global regulatory support
+ 0
All certificates
Replies quickly
Distributor
Produced in:
Established in: 1923
MOQ: 25 kg
Employees: 20+
Service-oriented company
Global supply chain resilience
Support of your new projects from start to commercial realisation
+ 0
All certificates
Replies quickly
Producer
+ 0
All certificates
Replies slower than most
Producer
+ 0
All certificates
Replies slower than most
Producer
+ 0
All certificates
Replies slower than most
Producer
+ 0
All certificates
Replies slower than most
Producer
+ 0
All certificates
Replies slower than most
Producer
+ 0
All certificates
Replies slower than most
Producer
+ 0
All certificates
Replies slower than most
Distributor
+ 0
All certificates
Not active
Producer
+ 0
All certificates
Not active
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Ribavirin API 36791-04-5?
- Description:
- Here you will find a list of producers, manufacturers and traders of Ribavirin. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Ribavirin
- Synonyms:
- RBV , Ribavirin , Ribavirina , Ribavirine , Ribavirinum , Tribavirin
- Cas Number:
- 36791-04-5
- DrugBank number:
- DB00811
- Unique Ingredient Identifier:
- 49717AWG6K
About Ribavirin
You can find a short description about Ribavirin here. Producing a broad-spectrum activity against several RNA and DNA viruses, Ribavirin is a synthetic guanosine nucleoside and antiviral agent that interferes with the synthesis of viral mRNA. It is primarily indicated for use in treating hepatitis C and viral hemorrhagic fevers. HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients It is reported that ribavirin might be only effective in early stages of viral hemorrhagic fevers including Lasser fever, Crimean-Congo hemorrhagic fever, Venezuelan hemorrhagic fever, and Hantavirus infection.
Ribavirin is a prodrug that is metabolized into nucleoside analogs that blocks viral RNA synthesis and viral mRNA capping. Before the development of newer drugs, ribavirin and Peginterferon alfa-2a/Peginterferon alfa-2b dual therapy was considered the first-generation and standard antiviral treatment The dual therapy was administered for 48 weeks in patients with genotype and and 24 weeks in patients with genotype 2 and 3 Newer drugs developed as Hepatitis C viral infection treatments can be used to reduce or eliminate the use of ribavirin, which are associated with serious adverse effects. They also improve therapeutic efficacy in patients with failed Peginterferon alfa-2a/Peginterferon alfa-2b and ribavirin-based therapy. The potential use of ribavirin as a treatment for acute myeloid leukemia is currently under investigation. According to 2017 American Association for the Study of Liver Diseases (AASLD) and 2015 consensus guidelines from the Canadian Association for the Study of the Liver (CASL), ribavirin is typically used as an adjunct therapy to various first-line and second-line combination therapies recommended for each genotypes. Ribavirin is added to decrease relapse rates by accelerating viral clearance early in the treatment course.
Ask the supplier for a certificate of analysis to find out more about the quality of Ribavirin.
Ribavirin is a type of Anti-HCV agents
Anti-HCV agents, belonging to the pharmaceutical API category, are potent medications used in the treatment of Hepatitis C Virus (HCV) infection. Hepatitis C is a viral disease that affects the liver and can lead to severe health complications if left untreated. Anti-HCV agents work by targeting specific mechanisms involved in the replication and spread of the HCV virus within the body.
These pharmaceutical APIs are designed to inhibit various steps of the viral lifecycle, including viral entry into liver cells, viral RNA replication, and assembly of new viral particles. By disrupting these critical processes, anti-HCV agents effectively reduce the viral load in the body, slow down disease progression, and ultimately improve patient outcomes.
The development of anti-HCV agents has revolutionized the management of HCV infection, offering new hope for patients. These APIs are often used in combination with other antiviral drugs to form highly effective treatment regimens known as direct-acting antiviral (DAA) therapies. DAAs have significantly higher cure rates compared to older treatment options, such as interferon-based therapies, and are associated with fewer side effects.
The pharmaceutical industry has made significant advancements in the development of anti-HCV agents, resulting in a diverse range of APIs with varying mechanisms of action. This diversity allows healthcare professionals to tailor treatment plans based on the specific characteristics of each patient's HCV infection, maximizing the chances of successful viral eradication.
In summary, anti-HCV agents are a crucial category of pharmaceutical APIs used in the treatment of Hepatitis C. Their targeted action against the HCV virus has revolutionized the management of this chronic infection, providing more effective and better-tolerated treatment options for patients.
Ribavirin manufacturers | traders | suppliers
We have 11 companies offering Ribavirin produced in 6 different countries.
Get in contact with the supplier of your choice:
- LGM Pharma from United States, product country of origin World
- Otto Brandes GmbH from Germany, product country of origin Unknown
- Euticals from Italy, product country of origin Unknown
- Star Lake Bioscience from China, product country of origin China
- Yamasa Corp. from Japan, product country of origin Japan
- Zhejiang Chengyi from China, product country of origin China
- Yuhan Chemical from South Korea, product country of origin South Korea
- Jinan Mingxin from China, product country of origin China
- Bidachem from Italy, product country of origin Italy
- Shaoxing Hantai Pharma from China, product country of origin China
- Siegfried from Germany, product country of origin Unknown
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.
